First-in-human study and clinical case reports of the alveolar bone regeneration with the secretome from human mesenchymal stem cells
Conclusions:
MSC-CM was used safely and with less inflammatory signs and appears to have great osteogenic potential for regenerative medicine of bone. This is the first in-human clinical study of alveolar bone regeneration using MSC-CM.
Source: Epidemiologic Perspectives and Innovations - Category: Epidemiology Authors: Wataru KatagiriMasashi OsugiTakamasa KawaiHideharu Hibi Source Type: research
More News: Epidemiology | Insulin | Medical Ethics | Radiography | Stem Cell Therapy | Stem Cells | Study